(Q43857234)

27 November 2017

title

Adverse neuropsychiatric effects of dopamine antagonist medications. Misdiagnosis in the medical setting (English)

1 reference

27 November 2017

1 reference

1

Ferrando SJ

1 reference

27 November 2017

Eisendrath SJ

2

1 reference

27 November 2017

publication date

1 January 1991

1 reference

27 November 2017

1 reference

27 November 2017

volume

32

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

426-432

1 reference

Drug therapy. Metoclopramide

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Drug-induced extrapyramidal symptoms. A cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

The action of thiethylperazihe torecan®), a new anti-emetic, compared with perphenazine (trilafon®), trmethobenzamide (tigan®), and a placeeio in the; suppression of postanaesthetic nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptics and neurologic reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Tardive dyskinesia associated with high-dose intravenous metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Tardive dyskinesia associated with metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

The AIDS dementia complex: II. Neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Metoclopramide-induced neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic Malignant Syndrome Associated With Metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic malignant-like syndrome induced by metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Current concepts. Neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic malignant syndrome: response to dantrolene sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Severe parkinsonism in two AIDS patients taking prochlorperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Trimethobenzamide HCl in the treatment of nausea and vomiting associated with antineoplastic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

Neuroleptic malignant syndrome associated with metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2891%2972046-X

7 January 2021

10.1016/S0033-3182(91)72046-X

Identifiers

DOI

0 references

1 reference